Skip to main content

Akero Therapeutics, Inc.

AKRODelisted Dec 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001744659

Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Akero Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Akero Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Akero Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Harrison Seth LoringDirector0Dec 9, 20251
Iwicki Mark TDirector0Dec 9, 20251
Henderson JaneDirector0Dec 9, 20251
Gangloff Scott A.Chief Technology Officer0Dec 9, 20251
Graham G. WalmsleyDirector0Dec 9, 20252
Cheng AndrewPresident and CEO0Dec 9, 20255
White William RichardChief Financial Officer0Dec 9, 20251
Yale CatrionaChief Development Officer0Dec 9, 20252
Rolph TimothyChief Scientific Officer0Dec 9, 20254
Young JonathanChief Operating Officer0Dec 9, 20253
Heyman Tomas J.Director0Dec 9, 20251
Xu YuanDirector0Dec 9, 20251
Judy ChouDirector0Dec 9, 20251
Lamy PatrickSee Remarks0Dec 9, 20251
Ezbon International LtdOther: Former 10% owner3,271,829IndirectDec 5, 20220
Blue Horizon Enterprise LtdOther: Former 10% owner3,271,829IndirectDec 5, 20220
Montrago Trustees LtdOther: Former 10% owner3,271,829IndirectDec 5, 20220
Skorpios TrustOther: Former 10% owner3,271,829IndirectDec 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 6, 2021 (view filing)Jul 24 daysCheng AndrewPresident & CEOSSale−17.5K$24.78−$433.6K−4.9%342.5K after
Jul 8, 2021 (view filing)Jul 62 daysWhite William RichardChief Financial OfficerSSale−6.50K$24.52−$159.4K−66.5%3.28K after
Jul 19, 2021 (view filing)Jul 154 daysYale CatrionaChief Development OfficerSSale−10.0K$20.90−$209.0K−6.0%155.9K after
Aug 4, 2021 (view filing)Aug 31 dayCheng AndrewPresident & CEOSSale−17.5K$20.83−$364.6K−5.1%326.0K after2 lots
Aug 4, 2021 (view filing)Aug 22 daysWhite William RichardChief Financial OfficerSSale−4.44K$22.03−$97.8K−57.5%3.28K after
Aug 17, 2021 (view filing)Aug 161 dayYale CatrionaChief Development OfficerSSale−10.0K$18.79−$187.9K−6.4%145.9K after
Sep 3, 2021 (view filing)Sep 21 dayCheng AndrewPresident & CEOSSale−17.5K$23.89−$418.1K−5.4%308.5K after
Sep 3, 2021 (view filing)Sep 12 daysWhite William RichardChief Financial OfficerSSale−8.56K$24.00−$205.4K−72.3%3.28K after
Sep 3, 2021 (view filing)Sep 12 daysYoung JonathanChief Operating OfficerSSale−12.5K$24.04−$300.5K−7.2%160.5K after
Sep 17, 2021 (view filing)Sep 152 daysYale CatrionaChief Development OfficerSSale−12.5K$24.69−$308.6K−8.6%133.4K after2 lots
Oct 5, 2021 (view filing)Oct 14 daysWhite William RichardChief Financial OfficerSSale−6.50K$22.06−$143.4K−66.5%3.28K after
Oct 5, 2021 (view filing)Oct 41 dayCheng AndrewPresident & CEOSSale−17.5K$21.54−$376.9K−5.7%291.0K after
Oct 18, 2021 (view filing)Oct 153 daysYale CatrionaChief Development OfficerSSale−12.5K$21.59−$269.8K−9.4%120.9K after2 lots
Nov 3, 2021 (view filing)Nov 12 daysWhite William RichardChief Financial OfficerSSale−6.50K$22.24−$144.6K−66.5%3.28K after
Nov 3, 2021 (view filing)Nov 21 dayCheng AndrewPresident & CEOSSale−17.5K$22.57−$395.0K−6.0%273.5K after
Nov 5, 2021 (view filing)Nov 3-42 daysYoung JonathanChief Operating OfficerSSale−25.0K$24.28−$607.1K−15.6%135.5K after2 lots
Dec 3, 2021 (view filing)Dec 21 dayCheng AndrewPresident & CEOSSale−17.5K$20.18−$353.1K−6.4%256.0K after
Dec 20, 2021 (view filing)Dec 173 daysWhite William RichardChief Financial OfficerSSale−3.20K$22.04−$70.5K−49.4%3.28K after
Dec 23, 2021 (view filing)Dec 212 daysWhite William RichardChief Financial OfficerSSale−100$22.00−$2.20K−3.0%3.28K after
Jan 11, 2022 (view filing)Jan 10, 2021366 daysCheng AndrewPresident & CEOSSale−10.0K$19.55−$195.5K−3.2%299.0K afterFrom original
Jan 18, 2022 (view filing)Jan 144 daysWhite William RichardChief Financial OfficerSSale−9.70K$22.03−$213.7K−74.7%3.28K after
Feb 3, 2022 (view filing)Feb 12 daysCheng AndrewPresident & CEOSSale−10.0K$17.56−$175.6K−3.1%309.0K after
Mar 2, 2022 (view filing)Mar 11 dayCheng AndrewPresident & CEOSSale−10.0K$17.59−$175.9K−3.1%309.0K after
Sep 15, 2022 (view filing)Sep 132 daysWhite William RichardChief Financial OfficerSSale−32.5K$27.03−$878.3K−88.0%4.43K after2 lots
Sep 15, 2022 (view filing)Sep 132 daysYale CatrionaChief Development OfficerSSale−40.0K$27.48−$1.10M−32.8%82.1K after2 lots
Sep 15, 2022 (view filing)Sep 132 daysCheng AndrewPresident & CEOSSale−60.0K$27.42−$1.65M−16.2%310.1K after2 lots
Oct 4, 2022 (view filing)Sep 304 daysRolph TimothyChief Scientific OfficerSSale−45.0K$32.72−$1.47M−18.5%198.8K after2 lots
Oct 5, 2022 (view filing)Oct 32 daysCheng AndrewPresident & CEOSSale−10.0K$33.23−$332.3K−3.1%310.1K after3 lots
Oct 7, 2022 (view filing)Oct 61 dayRolph TimothyChief Scientific OfficerSSale−22.5K$39.29−$884.0K−10.8%186.3K after
Oct 12, 2022 (view filing)Oct 102 daysYale CatrionaChief Development OfficerSSale−5.00K$37.99−$189.9K−6.1%77.1K after
Oct 17, 2022 (view filing)Oct 134 daysWhite William RichardChief Financial OfficerSSale−20.0K$39.82−$796.4K−81.9%4.43K after
Oct 27, 2022 (view filing)Sep 1344 daysRolph TimothyChief Scientific OfficerSSale−22.5K$29.18−$656.5K−8.8%233.8K afterAmended
Oct 27, 2022 (view filing)Oct 252 daysYoung JonathanChief Operating OfficerSSale−12.5K$44.72−$559.0K−7.1%163.3K after
Oct 27, 2022 (view filing)Oct 25-262 daysRolph TimothyChief Scientific OfficerSSale−15.4K$45.07−$694.8K−7.5%190.9K after2 lots
Oct 27, 2022 (view filing)Oct 25-272 daysHarrison Seth LoringDirectorSSale−136.8K$42.71−$5.84M−44.8%168.5K after7 lots
Oct 27, 2022 (view filing)Oct 25-272 daysHarrison Seth LoringDirectorSSale−148.7K$42.71−$6.35M−44.8%183.1K after7 lots
Nov 1, 2022 (view filing)Oct 284 daysHarrison Seth LoringDirectorSSale−21.1K$40.31−$852.1K−12.5%147.4K after2 lots
Nov 1, 2022 (view filing)Oct 284 daysHarrison Seth LoringDirectorSSale−23.0K$40.31−$925.8K−12.5%160.1K after2 lots
Nov 2, 2022 (view filing)Nov 11 dayCheng AndrewPresident & CEOSSale−10.0K$43.42−$434.2K−3.1%310.1K after3 lots
Nov 14, 2022 (view filing)Nov 104 daysYale CatrionaChief Development OfficerSSale−5.00K$39.42−$197.1K−6.5%72.1K after2 lots
Nov 16, 2022 (view filing)Nov 15-161 dayRolph TimothyChief Scientific OfficerSSale−7.08K$45.28−$320.8K−3.7%183.8K after3 lots
Dec 2, 2022 (view filing)Nov 302 daysHarrison Seth LoringDirectorSSale−11.1K$46.94−$521.1K−7.5%136.3K after2 lots
Dec 2, 2022 (view filing)Nov 302 daysHarrison Seth LoringDirectorSSale−12.0K$46.94−$564.7K−7.5%148.1K after2 lots
Dec 2, 2022 (view filing)Dec 11 dayCheng AndrewPresident & CEOSSale−10.0K$46.07−$460.7K−3.1%310.1K after
Dec 5, 2022 (view filing)4:36 PM ETDec 14 daysEzbon International Ltd and 3 othersOther: Former 10% ownerSSale−1.64M$43.50−$71.2M−33.3%3.27M after
Dec 13, 2022 (view filing)Dec 121 dayYale CatrionaChief Development OfficerSSale−5.00K$43.23−$216.1K−5.5%86.3K after2 lots
Dec 28, 2022 (view filing)Dec 271 dayYoung JonathanChief Operating OfficerSSale−12.5K$49.57−$619.6K−6.4%182.4K after
Dec 29, 2022 (view filing)Dec 27-282 daysWhite William RichardChief Financial OfficerSSale−20.0K$49.77−$995.4K−45.8%23.6K after2 lots
Dec 30, 2022 (view filing)Dec 28-292 daysRolph TimothyChief Scientific OfficerSSale−22.0K$50.97−$1.12M−10.4%190.5K after3 lots
Jan 5, 2023 (view filing)Jan 32 daysYoung JonathanChief Operating OfficerSSale−8.78K$54.64−$479.6K−4.5%184.9K after